Institutional Ownership Cullinan Oncology, Inc. (CGEM)
This table provides information about the institutional ownership of Cullinan Oncology, Inc. (CGEM). We have compiled data on the 153 institutions that hold shares in the stock, with a total of 66.5 Million shares, which have been reported (via 13F filing form) to have a value of $455 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
626,581
shares
|
$4.28 Million
0.01% of portfolio
|
Q2 2025
Added 10.31%
|
|
Twin Focus Capital Partners, LLC
Boston, MA |
Aug 12, 2025 Q2 2025 |
595,489
shares
|
$4.07 Million
0.66% of portfolio
|
Q2 2024
New holding
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Aug 12, 2025 Q2 2025 |
594,025
shares
|
$4.06 Million
2.51% of portfolio
|
Q2 2025
Reduced 6.39%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
566,781
shares
|
$3.87 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.52%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
510,828
shares
|
$3.49 Million
0.0% of portfolio
|
Q2 2025
Reduced 34.77%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
453,203
shares
|
$3.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 6.34%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
435,516
shares
|
$2.97 Million
0.0% of portfolio
|
Q2 2025
Added 2.65%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
334,525
shares
|
$2.28 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.85%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
311,309
shares
|
$2.13 Million
0.0% of portfolio
|
Q2 2025
Added 11.65%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
268,467
shares
|
$1.83 Million
0.0% of portfolio
|
Q2 2025
Added 11.24%
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
263,817
shares
|
$1.8 Million
0.33% of portfolio
|
Q2 2024
Added 2.02%
|
|
Voss Capital, LLC
Houston, TX |
Aug 13, 2025 Q2 2025 |
251,717
shares
|
$1.72 Million
0.16% of portfolio
|
Q2 2025
Added 43.84%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
242,092
shares
|
$1.65 Million
0.0% of portfolio
|
Q2 2025
Reduced 49.76%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
227,033
shares
|
$1.55 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.8%
|
|
Algert Global LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
215,580
shares
|
$1.47 Million
0.03% of portfolio
|
Q2 2025
Reduced 2.64%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
186,083
shares
|
$1.27 Million
0.0% of portfolio
|
Q2 2025
Added 15.54%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
180,685
shares
|
$1.23 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.91%
|
|
Caption Management, LLC
Oklahoma City, OK |
Aug 14, 2025 Q2 2025 |
175,427
shares
|
$1.2 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
Verition Fund Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
139,660
shares
|
$953,877
0.01% of portfolio
|
Q2 2025
Added 378.7%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
129,918
shares
|
$887,339
0.0% of portfolio
|
Q2 2025
Added 63.55%
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
125,189
shares
|
$855,040
0.0% of portfolio
|
Q2 2025
Added 11.11%
|
|
Trexquant Investment LP
Stamford, CT |
Aug 12, 2025 Q2 2025 |
119,342
shares
|
$815,105
0.01% of portfolio
|
Q2 2025
Added 74.31%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
106,580
shares
|
$727,941
0.0% of portfolio
|
Q2 2025
Added 32.64%
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
74,105
shares
|
$506,137
0.0% of portfolio
|
Q2 2025
Added 3.88%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Aug 07, 2025 Q2 2025 |
70,044
shares
|
$478,400
0.0% of portfolio
|
Q2 2025
Reduced 9.76%
|